Ryman Healthcare Limited (RYHTY)
OTCMKTS · Delayed Price · Currency is USD
7.11
0.00 (0.00%)
Oct 15, 2025, 8:00 PM EDT
Ryman Healthcare Revenue
In the fiscal year ending March 31, 2025, Ryman Healthcare had annual revenue of 759.16 million NZD with 10.41% growth. Ryman Healthcare had revenue of 394.01 million in the half year ending March 31, 2025, with 28.03% growth.
Revenue
759.16M NZD
Revenue Growth
+10.41%
P/S Ratio
3.69
Revenue / Employee
98.59K NZD
Employees
7,700
Market Cap
1.59B USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 759.16M | 71.60M | 10.41% |
| Mar 31, 2024 | 687.56M | 105.95M | 18.22% |
| Mar 31, 2023 | 581.61M | 72.86M | 14.32% |
| Mar 31, 2022 | 508.76M | 53.07M | 11.64% |
| Mar 31, 2021 | 455.69M | 32.36M | 7.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Ryman Healthcare News
- 24 days ago - NZ’s biggest aged care provider to debut on ASX next week - The Australian Financial Review
- 5 months ago - Ryman Healthcare Limited (RYHTY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 months ago - Ryman Healthcare Ltd (RHCGF) (H1 2025) Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 11 months ago - Half Year 2025 Ryman Healthcare Ltd Earnings Call Transcript - GuruFocus
- 11 months ago - Ryman Healthcare Limited (RYHTY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 11 months ago - Ryman Healthcare Limited GAAP EPS of $13.60c, revenue of $366.23M - Seeking Alpha
- 1 year ago - Ryman Healthcare bombshell: reviewing fixed weekly fees, DMF for new residents - NZ Herald
- 1 year ago - How Ryman Healthcare chairman Dean Hamilton plans to fix a financial disaster - NZ Herald